Utilizing database-based enrichment analysis, coupled with in vitro and in vivo pharmacological experiments, we discovered that inhibiting AKT/NLRP3 inflammasome activation attenuated inflammatory responses and pyroptosis, thereby ameliorating RIR-induced acute kidney injury. Here, AKT1 is linked to acute kidney injury.